Patents by Inventor Kent Morgan

Kent Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7154718
    Abstract: The present invention is directed to an electrical wiring protection device that includes a housing assembly having at least one receptacle. The receptacle is configured to receive plug contact blades inserted therein. The housing assembly includes a hot line terminal, a neutral line terminal, a hot load terminal, and a neutral load terminal. A set of receptacle contacts is disposed in the housing assembly and in communication with the receptacle. The receptacle contacts includes a hot user-accessible load contact and a neutral user accessible load contact. A fault detection circuit is coupled to the test assembly. The fault detection circuit is configured to detect at least one fault condition and provide a fault detect signal in response thereto. A four-pole interrupting contact assembly is coupled to the fault detection circuit and includes a set of four-pole interrupting contacts. A reset mechanism is coupled to the four-pole interrupting contact assembly.
    Type: Grant
    Filed: July 28, 2004
    Date of Patent: December 26, 2006
    Assignee: Pass & Seymour, Inc.
    Inventors: David A. Finlay, Sr., Kent Morgan, Patrick J. Murphy, Dejan Radosavljevic, Jeffrey C. Richards, Gerald R. Savicki, Jr., Richard Weeks, Gary Wilson
  • Patent number: 6982558
    Abstract: The present invention is directed to an electric circuit test device for testing an electric circuit. The test device is insertable into a receptacle. The receptacle includes electrical terminals coupled to the electrical circuit. The device includes a housing characterized by a longitudinal axis. A plug blade assembly is disposed within the housing and configured to mate with the electrical terminals. Electrical continuity is established between the plug blade assembly and the electric circuit. A fault detection circuit is coupled to the plug blade assembly and disposed within the housing. The fault detection circuit is configured to detect a circuit status condition in the electrical circuit. A circuit status indicator assembly is coupled to the fault detection circuit and disposed normal thereto. The circuit status indicator assembly includes semiconductor light indicators that are connected substantially normal to the circuit status indicator assembly.
    Type: Grant
    Filed: August 22, 2003
    Date of Patent: January 3, 2006
    Assignee: Pass & Seymour, Inc.
    Inventors: Michael Bryndzia, Kent Morgan
  • Publication number: 20040246003
    Abstract: The present invention is directed to an electric circuit test device for testing an electric circuit. The test device is insertable into a receptacle. The receptacle includes electrical terminals coupled to the electrical circuit. The device includes a housing characterized by a longitudinal axis. A plug blade assembly is disposed within the housing and configured to mate with the electrical terminals. Electrical continuity is established between the plug blade assembly and the electric circuit. A fault detection circuit is coupled to the plug blade assembly and disposed within the housing. The fault detection circuit is configured to detect a circuit status condition in the electrical circuit. A circuit status indicator assembly is coupled to the fault detection circuit and disposed normal thereto. The circuit status indicator assembly includes semiconductor light indicators that are connected substantially normal to the circuit status indicator assembly.
    Type: Application
    Filed: August 22, 2003
    Publication date: December 9, 2004
    Inventors: Michael Bryndzia, Kent Morgan
  • Patent number: 6281413
    Abstract: Novel nucleic acid sequences isolated from Photorhabdus luminescens, whose expression results in novel insecticidal toxins, are disclosed herein. The invention also discloses compositions and formulations containing the insecticidal toxins that are capable of controlling insect pests. The invention is further drawn to methods of making the toxins and to methods of using the nucleotide sequences, for example in microorganisms to control insect pests or in transgenic plants to confer insect resistance.
    Type: Grant
    Filed: February 17, 1999
    Date of Patent: August 28, 2001
    Assignee: Syngenta Participations AG
    Inventors: Vance Cary Kramer, Michael Kent Morgan, Arne Robert Anderson, Hope Prim Hart, Gregory W. Warren, Martha M. Dunn, Jeng Shong Chen
  • Patent number: 6277823
    Abstract: Novel nucleic acid sequences isolated from Xenorhabdus nematophilus, Xenorhabdus poinarii, and Photorhabdus luminescens, whose expression results in novel insecticidal toxins, are disclosed herein. The invention also discloses compositions and formulations containing the insecticidal toxins that are capable of controlling insect pests. The invention is further drawn to methods of making the toxins and to methods of using the nucleotide sequences, for example in microorganisms to control insect pests or in transgenic plants to confer insect resistance.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: August 21, 2001
    Assignee: Syngenta Participations AG
    Inventors: Vance Cary Kramer, Michael Kent Morgan, Arne Robert Anderson
  • Patent number: 6174860
    Abstract: Novel nucleic acid sequences isolated from Xenorhabdus nematophilus, Xenorhabdus poinarii, and Photorhabdus luminescens, whose expression results in novel insecticidal toxins, are disclosed herein. The invention also discloses compositions and formulations containing the insecticidal toxins that are capable of controlling insect pests. The invention is further drawn to methods of making the toxins and to methods of using the nucleotide sequences, for example in microorganisms to control insect pests or in transgenic plants to confer insect resistance.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: January 16, 2001
    Assignee: Novartis AG
    Inventors: Vance Cary Kramer, Michael Kent Morgan, Arne Robert Anderson